Royalty Pharma(RPRX) - 2025 Q4 - Earnings Call Transcript

Royalty Pharma (NasdaqGS:RPRX) Q4 2025 Earnings call February 11, 2026 08:00 AM ET Company ParticipantsAsh Verma - Executive Director of SMID Biotech and BiopharmaChris Hite - EVP and Vice ChairmanChristopher Schott - Managing DirectorGeoff Meacham - Managing DirectorGeorge Grofik - SVP and Head of Investor RelationsMarshall Urist - EVP and Head of Research and InvestmentsMike Nedelcovic - Director of Equity ResearchPablo Legorreta - CEO and Chairman of the BoardTerry Coyne - EVP and CFOUmer Raffat - Senior ...